JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

Search

Intuitive Surgical Inc

Cerrado

SectorSanidad

482.55 0.75

Resumen

Variación precio

24h

Actual

Mínimo

478.97

Máximo

482.74

Métricas clave

By Trading Economics

Ingresos

90M

800M

Ventas

361M

2.9B

P/B

Media del Sector

59.161

60.328

Margen de beneficios

27.894

Empleados

17,021

EBITDA

70M

1.1B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+20.32% upside

Dividendos

By Dow Jones

Próximas Ganancias

21 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-26B

165B

Apertura anterior

481.8

Cierre anterior

482.55

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

Intuitive Surgical Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

22 abr 2026, 15:47 UTC

Principales Movimientos del Mercado

Intuitive Surgical Shares Rise After 1Q Beat

21 abr 2026, 20:54 UTC

Ganancias

Intuitive Surgical Posts Higher 1Q Sales, Profit

22 abr 2026, 11:27 UTC

Ganancias

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

21 abr 2026, 21:14 UTC

Ganancias

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

21 abr 2026, 20:38 UTC

Ganancias

Intuitive Surgical 1Q Rev $2.77B >ISRG

21 abr 2026, 20:38 UTC

Ganancias

Intuitive Surgical 1Q Net $821.5M >ISRG

21 abr 2026, 20:38 UTC

Ganancias

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 431.00 >ISRG

21 abr 2026, 20:38 UTC

Ganancias

Intuitive Surgical 1Q Adj EPS $2.50 >ISRG

21 abr 2026, 20:38 UTC

Ganancias

Intuitive Surgical 1Q EPS $2.28 >ISRG

21 abr 2026, 20:14 UTC

Ganancias

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of About 13.5% to 15.5%

21 abr 2026, 20:14 UTC

Ganancias

Intuitive Surgical 1Q Rev $2.77B

21 abr 2026, 20:13 UTC

Ganancias

Intuitive Surgical 1Q Adj EPS $2.50

21 abr 2026, 20:12 UTC

Ganancias

Intuitive Surgical 1Q EPS $2.28

14 abr 2026, 14:13 UTC

Ganancias

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

14 abr 2026, 12:57 UTC

Ganancias

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

17 feb 2026, 14:48 UTC

Ganancias

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

23 ene 2026, 16:07 UTC

Ganancias

Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. -- Barrons.com

23 ene 2026, 12:58 UTC

Ganancias

Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. -- Barrons.com

22 ene 2026, 21:11 UTC

Ganancias

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 ene 2026, 21:11 UTC

Ganancias

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 ene 2026, 21:10 UTC

Ganancias

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 ene 2026, 21:05 UTC

Ganancias

Intuitive Surgical 4Q EPS $2.21 >ISRG

22 ene 2026, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Rev $2.87B >ISRG

22 ene 2026, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Net $794.8M >ISRG

22 ene 2026, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Adj EPS $2.53 >ISRG

22 ene 2026, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 532.00 >ISRG

30 oct 2025, 12:38 UTC

Ganancias

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30 oct 2025, 12:01 UTC

Ganancias

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22 oct 2025, 15:42 UTC

Ganancias

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 oct 2025, 12:34 UTC

Ganancias

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

Comparación entre iguales

Cambio de precio

Intuitive Surgical Inc previsión

Precio Objetivo

By TipRanks

20.32% repunte

Estimación a 12 Meses

Media 580.2 USD  20.32%

Máximo 670 USD

Mínimo 451 USD

De acuerdo con 20 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Intuitive Surgical Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

20 ratings

15

Comprar

5

Mantener

0

Vender

Puntuación técnica

By Trading Central

514.59 / 539.05Soporte y Resistencia

Corto Plazo

Weak Bearish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.